Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study
- PMID: 33197472
- PMCID: PMC7666537
- DOI: 10.1016/j.jinf.2020.11.012
Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study
Abstract
Background: Angiotensin converting enzyme (ACE) genotypes are known to be associated with development of acute respiratory distress syndrome (ARDS) and resultant mortality. In the present study, we examined the association between distribution frequency of ACE genotypes and COVID-19 mortality.
Methods: We undertook an ecological study to examine the association between ACE genotypes and COVID-19 mortality across 25 countries to represent different geographical regions of the world. The population frequencies of ACE genotypes were drawn from previously published reports and data on COVID-19-related mortality were extracted from 'Worldometer'. Multivariable analyses were also undertaken adjusting for age (median age), sex (percentage of females) and the number of COVID-19 tests undertaken. Associations between genotypes deletion/deletion (DD) and insertion/insertion (II) prevalence and COVID-19-related mortality (per million people per day since the first diagnosed case) were evaluated.
Results: The frequency of II genotype is highest in east Asian countries and lower among the European and African countries. An inverse geographical distribution frequency was noted for DD genotype. Increasing II genotype frequency was significantly associated with decreased COVID-19 mortality rates (adjusted incident rate ratio [IRR] 0.3, 95% confidence interval [CI]: 0.002-0.7, p = 0.03). However, no association was found between DD genotype frequency and COVID-19 mortality rates (adjusted IRR 4.3, 95% CI: 0.5-41.2, p = 0.2).
Conclusions: Distribution frequency of ACE insertion/insertion (II) genotype may have a significant influence on COVID-19 mortality. This information has potential utility for resource planning at a systemic level, as well as for clinical management.
Keywords: Epidemiology; Genotype; Mortality; Viral pneumonia.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest None to declare.
Figures


Comment in
-
Lack of significant association between dyslipidemia and COVID-19 mortality.J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.001. Epub 2021 Mar 5. J Infect. 2021. PMID: 33684401 Free PMC article. No abstract available.
-
ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.002. Epub 2021 Jun 16. J Infect. 2021. PMID: 34097930 Free PMC article. No abstract available.
-
An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.J Infect. 2022 Jan;84(1):e21-e22. doi: 10.1016/j.jinf.2021.10.020. Epub 2021 Oct 30. J Infect. 2022. PMID: 34728265 Free PMC article. No abstract available.
References
-
- Organization W.H. Vol. 154. 2020. Coronavirus disease 2019 (COVID-19): situation report. (Coronavirus disease 2019 (COVID-19): situation report).
-
- Joint Task Force on Practice Parameters Executive summary of disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol. 1999;83:665–700. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous